The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment

被引:60
作者
Egan, James E. [1 ]
Casadonte, Paul [2 ]
Gartenmann, Tracy [3 ]
Martin, Judith [4 ]
McCance-Katz, Elinore F. [5 ]
Netherland, Julie [1 ]
Renner, John A. [6 ,7 ]
Weiss, Linda [1 ]
Saxon, Andrew J. [8 ,9 ]
Fiellin, David A. [10 ]
机构
[1] New York Acad Med, New York, NY 10029 USA
[2] NYU, Sch Med, New York, NY USA
[3] ASAM, Chevy Chase, MD USA
[4] BAART Turk St Clin, San Francisco, CA USA
[5] Univ Calif San Francisco, San Francisco, CA 94143 USA
[6] Boston Univ, Sch Med, Boston, MA 02118 USA
[7] VA Boston Healthcare Syst, Boston, MA USA
[8] Univ Washington, Addict Care Line VA Puget Sound Hlth Care Syst, Seattle, WA 98195 USA
[9] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA
[10] Yale Univ, Sch Med, New Haven, CT USA
关键词
buprenorphine; opioid-related disorders; primary health care; education; distance; PRIMARY-CARE; METHADONE-MAINTENANCE; DEPENDENCE; USERS;
D O I
10.1007/s11606-010-1377-y
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Opioid dependence is largely an undertreated medical condition in the United States. The introduction of buprenorphine has created the potential to expand access to and use of opioid agonist treatment in generalist settings. Physicians, however, often have limited training and experience providing this type of care. Some physicians believe having a mentoring relationship with an experienced provider during their initial introduction to the use of buprenorphine would ease implementation. Our goal was to describe the development, implementation, resources, and evaluation of the Physician Clinical Support System-Buprenorphine (PCSS-B), a federally funded program to improve access to and quality of treatment with buprenorphine. We provide a description of the PCSS-B, a national network of 88 trained physician mentors with expertise in buprenorphine treatment and skills in clinical education. We provide information regarding the use the PCSS-B core services including telephone, email and in-person support, a website, clinical guidances, a warmline and outreach to primary care and specialty organizations. Between July 2005 and July 2009, 67 mentors and 4 clinical experts reported providing mentoring services to 632 participants in 48 states, Washington DC and Puerto Rico. A total of 1,455 contacts were provided through email (45%), telephone (34%) and in-person visits (20%). Seventy-six percent of contacts addressed a clinical issue. Eighteen percent of contacts addressed a logistical issue. The number of contacts per participant ranged from 1-125. Between August 2005 and April 2009 there were 72,822 visits to the PCSS-B website with 179,678 pages viewed. Seven guidances were downloaded more than 1000 times. The warmline averaged more than 100 calls per month. The PCSS-B model provides support for a mentorship program to assist non-specialty physicians in the provision of buprenorphine and may serve as a model for dissemination of other types of care.
引用
收藏
页码:936 / 941
页数:6
相关论文
共 39 条
[1]  
*BOST U SCH PUBL H, 2003, NAT POLL PHYS FINDS
[2]  
Cunningham CO, 2006, FAM MED, V38, P336
[3]  
*DHHS, 2008, DHHS PUBL
[4]  
ELLIOTT V, 2001, AM MED NEWS 0129
[5]   Consensus statement on office-based treatment of opioid dependence using buprenorphine [J].
Fiellin, DA ;
Kleber, H ;
Trumble-Hejduk, JG ;
McLellan, AT ;
Kosten, TR .
JOURNAL OF SUBSTANCE ABUSE TREATMENT, 2004, 27 (02) :153-159
[6]   Guideline development for office-based pharmacotherapies for opioid dependence [J].
Fiellin, DA ;
Barthwell, AG .
JOURNAL OF ADDICTIVE DISEASES, 2003, 22 (04) :109-120
[7]   New federal initiatives to enhance the medical treatment of opioid dependence [J].
Fiellin, DA ;
O'Connor, PG .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (08) :688-692
[8]   Methadone maintenance in primary care - A randomized controlled trial [J].
Fiellin, DA ;
O'Connor, PG ;
Chawarski, M ;
Pakes, JP ;
Pantalon, MV ;
Schottenfeld, RS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (14) :1724-1731
[9]  
FIELLIN DA, 2004, AM J ADDICTION S1, V13, P67
[10]   The first three years of buprenorphine in the united states: Experience to date and future directions [J].
Fiellin, David A. .
JOURNAL OF ADDICTION MEDICINE, 2007, 1 (02) :62-67